Quality indicators for appropriate medication use in vulnerable elders.
Knight
E L
EL
Channing Laboratory, 181 Longwood Avenue, Boston, MA 02118, USA.
Avorn
J
J
D000368:Aged; D000701:Analgesics, Opioid; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001463:Barbiturates; D002747:Chlorpropamide; D018680:Cholinergic Antagonists; D000075202:Contraindications; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D011307:Drug Prescriptions; D004358:Drug Therapy / Q000706:statistics & numerical data; D064420:Drug-Related Side Effects and Adverse Reactions; D019317:Evidence-Based Medicine; D016330:Frail Elderly; D006299:Health Services for the Aged / Q000592:standards*; D006801:Humans; D007004:Hypoglycemic Agents; D007677:Kidney Function Tests; D008614:Meperidine; D008991:Monitoring, Physiologic; D010353:Patient Education as Topic; D019984:Quality Indicators, Health Care; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000701:Analgesics, Opioid; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D001463:Barbiturates; D018680:Cholinergic Antagonists; D004232:Diuretics; D007004:Hypoglycemic Agents; D014859:Warfarin; D008614:Meperidine; D002747:Chlorpropamide